The market is absorbing the hawkish pivot from Federal Reserve Chair Jerome Powell after he said it’s time to retire the word transitory to describe the inflation outlook. After his remarks, money markets estimated a 50-50 chance the Fed will hike rates as early as May (Bloomberg)
Market Update
FDA says Merck COVID-19 pill is effective against virus, experts still to review safety
National News
There are fears this morning about a new strain of Covid-19 that’s rapidly spreading in southern Africa. The European Union and the U.K. are already moving to halt air travel from the region (Bloomberg)
Market Update
South Korea reported an outbreak of a highly pathogenic avian influenza at a farm of around 770,000 poultry, all were euthanized. Norway also reported bird flu outbreak in a flock of 7,000 birds.
World Ag News
Oil Tumbles as U.S. Piles Pressure Onto OPEC+ for More Barrels (BN Commodities)
NBW Market Commmentary
CDC gives final approval to Pfizer/BioNTech COVID-19 vaccine for use in children aged 5 to 11; shots expected to become available within days
National News
Elon Musk Will Sell $6 Billion Worth of Tesla Stock to Solve World Hunger if UN Can Explain How It’ll Spend It
National News
Australia on Thursday ruled out promising to cut methane emissions by 30% by the end of the decade in a stance that will add to criticism that the country is a laggard in addressing climate change.
World News
Pfizer and BioNTech release data demonstrating 95.6% efficacy of booster shots in protecting against COVID-19 infection compared to a placebo, including against the Delta variant
National News
Tesla and SpaceX's Elon Musk is now worth $230 billion following a share sale at SpaceX, making him richer than Bill Gates and Warren Buffett combined
National News
The U.S. will reopen its land borders to nonessential travel next month, ending a 19-month freeze due to the COVID-19 pandemic as the country moves to require all international visitors to be vaccinated
National News
AstraZeneca requests emergency use authorization for COVID-19 antibody treatment for use in immunocompromised patients
National News
An antiviral pill developed by Merck & Co (MRK.N) could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, according to data that experts hailed as a potential breakthrough in how the virus is treated.
National News